Dr Paul Liknaitzky: Future directions for Psychedelic Research Video
Beyond the Trip: A Psychedelic Therapy Podcast with Dr Esme DarkShow Notes
In this episode, I talk with Dr Paul Liknaitzky, Head of the Clinical Psychedelic Lab at Monash University. 🌱
We explore Paul's journey into psychedelic science and therapy, challenges & opportunities in psychedelic rescheduling in Australia, The critical skills needed for psychedelic therapists, future directions for psychedelic research, and why collaboration is key in this space
Paul is Head of the Clinical Psychedelic Lab and a l [https://www.monash.edu/medicine/scs/clinical-psychedelic-lab/home]Senior Research Fellow in the Department of Psychiatry at Monash University. He has played a central role in establishing the field of clinical psychedelic research in Australia and is the principal investigator on a program of psychedelic trials. He is involved in numerous psychedelic studies across the country and collaborates with many international experts and organisations in the field. He has led several world-first studies, including the first trial to use psilocybin in the treatment of a primary anxiety condition, the first study testing the utility of psilocybin as a therapist training tool, and the first trial testing a psychedelic-augmented virtual-reality treatment.
keep in touch with me at Insta: dresmedark
Linkedin: www.linkedin.com/in/dr-esme-dark-627156a0/
website: https://www.esmedarkpsychology.com.au/
Find Paul and Monash Clinical Psychedelic Lab at www.monash.edu/psychedelics
Disclaimer: This podcast if for general information only and does not constitute an endorsement or recommendation for psychedelic- assisted psychotherapy.
More from Beyond the Trip: A Psychedelic Therapy Podcast with Dr Esme Dark
In this episode of Beyond the Trip, I'm joined by Associate Professor Vanessa Beesley, a behavioural scientist and Team Head of the Psychedelic Medicine and Supportive Care Group at QIMR Berghofer Medical Research Institute, to explore the intersection of grief, psychedelic-assisted therapy and supportive care.
What happens when a radically different approach to mental health treatment meets an established healthcare system?
In this episode, I'm joined by Pedram Dara, founder and director of Psychedelic Lived Experiences, a global patient-led initiative working to bring lived experience into the heart of psychedelic research, clinical practice, and policy.
Welcome to Part 2 of my interview series with Dr Marg Ross, clinical psychologist and Chief Principal Investigator of Australia's first psychedelic-assisted therapy trial exploring psilocybin for end-of-life distress.
Beyond the Trip is delighted to be collaborating with Kyle Buller from Psychedelics Today for this episode, where we discuss many topics, including